ZANUS, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 17.673
EU - Europa 3.261
AS - Asia 1.919
SA - Sud America 29
AF - Africa 21
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.915
Nazione #
US - Stati Uniti d'America 17.632
IT - Italia 1.518
CN - Cina 910
SG - Singapore 638
FI - Finlandia 431
FR - Francia 281
DE - Germania 253
SE - Svezia 250
VN - Vietnam 224
UA - Ucraina 215
GB - Regno Unito 151
IN - India 74
IE - Irlanda 43
CA - Canada 26
NL - Olanda 22
ES - Italia 19
PH - Filippine 18
BR - Brasile 15
PL - Polonia 12
HK - Hong Kong 11
GR - Grecia 10
PT - Portogallo 10
BE - Belgio 8
JP - Giappone 8
AU - Australia 7
EC - Ecuador 7
AT - Austria 6
RU - Federazione Russa 6
BZ - Belize 5
CR - Costa Rica 5
MY - Malesia 5
NG - Nigeria 5
SC - Seychelles 5
IR - Iran 4
MX - Messico 4
RO - Romania 4
TR - Turchia 4
AM - Armenia 3
NZ - Nuova Zelanda 3
PE - Perù 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
GH - Ghana 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
PK - Pakistan 2
SA - Arabia Saudita 2
SI - Slovenia 2
TH - Thailandia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SZ - Regno dello Swaziland 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 22.915
Città #
Fairfield 2.850
Woodbridge 1.675
Chandler 1.607
Houston 1.399
Ann Arbor 1.322
Ashburn 1.179
Seattle 1.062
Wilmington 954
Cambridge 945
Jacksonville 754
Singapore 474
Princeton 395
San Diego 350
Des Moines 321
Padova 258
Beijing 229
Dong Ket 224
Medford 205
Helsinki 201
Nanjing 145
Roxbury 140
Boardman 131
Santa Clara 93
Guangzhou 65
Milan 61
Shenyang 60
Nanchang 57
New York 52
Falls Church 50
Rome 41
Dearborn 39
Dublin 39
Hebei 39
Jiaxing 37
London 35
Changsha 33
Norwalk 29
Jinan 28
Bologna 27
Shanghai 25
Tianjin 25
Chicago 24
Ogden 24
Redwood City 24
Florence 19
Lappeenranta 19
Los Angeles 17
Pune 16
San Jose 16
Boisar 15
Mestre 15
Bari 14
Las Vegas 14
Vicenza 14
Munich 13
Verona 13
Brescia 12
Kharkiv 12
Portici 12
Selvazzano Dentro 12
Zhengzhou 12
Dallas 11
Hefei 11
Kilburn 11
Kunming 11
Mira 11
Ningbo 11
Paris 11
Detroit 9
Hong Kong 9
Indiana 9
Napoli 9
Palermo 9
Pescara 9
Redmond 9
Rockville 9
Taizhou 9
Trento 9
Buffalo 8
Catania 8
Chiswick 8
Hangzhou 8
Lanzhou 8
Modena 8
Prescot 8
Treviso 8
Venezia 8
Venice 8
Amsterdam 7
Essen 7
Legnaro 7
Porto 7
Quito 7
Southwark 7
Udine 7
Washington 7
Ancona 6
Borås 6
Frankfurt am Main 6
Pisa 6
Totale 18.299
Nome #
TRAPIANTO DI FEGATO CON EMITRASPOSIZIONE PORTO-CAVALE IN PAZIENTE CON BASM SYNDROME 683
Salvataggio d’organo attraverso emitrasposizione porto-cavale in trombosi porto-spleno- meseraica acuta dopo OLTx
G. 235
Termoablazione con microonde nel trattamento della recidiva locale di epatocarcinoma dopo trapianto ortotopico di fegato.
 177
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 173
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 172
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 163
Alcohol abuse and de novo tumors in liver transplantation 157
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 154
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 152
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 149
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 149
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 148
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 146
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 146
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 144
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 143
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 141
Prospective validation of the Barcelona Clinic Liver Cancer staging system 141
A New Liver Autotransplantation Technique Using Subnormothermic Machine Perfusion for Organ Preservation in a Porcine Model 140
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 133
A new experimental model of isolated perfused pig liver to support acute hepaticfailure. 133
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 132
Reply: The easiest way to improve the outcome of suboptimal liver grafts 130
The survival benefit of liver transplantation in hepatocellular carcinoma patients 129
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 129
Hepatitis C Virus Adversely Affects Quality of Life 128
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 128
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 127
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 126
A comparative prospective study of two available solutions for kidney and liver preservation 125
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 125
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries 123
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 122
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 122
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 121
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 121
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 120
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 119
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 119
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 119
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 119
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 118
Covert hepatic encephalopathy: agreement and predictive validity of different indices 118
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 118
EXTREME MARGINAL DONOR: SEVERE HYPOTHERMIA AS A RARE PRESERVATION CONDITION FOR EXPLANTABLE ORGANS - A CASE REPORT 117
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 117
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 115
Meld-na and Survival Benefit In Liver Transplantation 115
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report. 115
Central Nervous System Infectious Complications Early After Liver Transplantation 114
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 112
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 112
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 112
Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation 111
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. 111
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 111
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 110
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins 110
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 110
Endoscopic treatment of bile duct complications after orthotopic livertransplantation. 109
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 108
Liver transplantation for the management of hepatoblastoma 107
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 107
Intensive Care Unit Admission of Decompensated Cirrhotic Patients: Prognostic Scoring Systems 106
A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy. 105
Neoadjuvant Therapy Protocol and Liver Transplantation in Combination With Pancreatoduodenectomy for the Treatment of Hilar Cholangiocarcinoma Occurring in a Case of Primary Sclerosing Cholangitis: Case Report With a More Than 8-Year Disease-Free Survival 105
Expression of squamous cell carcinoma antigen in hepatocellular carcinoma and its precursors 104
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 104
Long-term follow-up after liver transplantation for blunt hepatic trauma 104
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 104
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma 104
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 103
Multimodal therapy before liver transplantation for hepatocellular carcinoma. 103
Split and whole liver transplantation outcomes: a comparative cohort study. 102
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature. 102
Blunt liver injury: from non-operative management to liver transplantation 102
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 102
Perianal tailgut cyst 102
Sequential versus "ab initio" combined diuretic treatment of moderate ascites in cirrhotic patients: Preliminary results of a randomized controlled multicenter clinical study 101
THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 101
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 100
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation 100
ESTIMATION OF THE HARM TO THE WAITING LIST AS CRUCIAL FACTOR IN THE SELECTION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION 99
Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report 99
Laparoscopic treatment of simple hepatic cysts and polycystic liver disease 99
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. 98
Risk Factors in Liver Retransplantation: A Single-Center Experience RID D-7140-2011 98
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 98
Combined liver and kidney transplantation: analysis of Padova experience. 98
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma 98
Pegylated Liposomal Doxorubicin and Gemcitabine in Patients With Advanced Hepatocellular Carcinoma Results of a Phase 2 Study 98
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 97
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report 97
The survival benefit of laparoscopic ablation over trans-arterial chemoembolization in patients with hepatocellular carcinoma ineligible for liver resection or percutaneous ablation 97
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 96
Liver transplantation using suboptimal grafts: impact of donor harvesting technique. 96
Risk Factors for Early Mortality in Liver Transplant Patients 96
Cytopathological findings in a siderotic liver nodule 96
Liver autotransplantation for the treatment of unresectable hepatic metastasis: an uncommon indication-a case report. 96
Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial 95
Totale 12.445
Categoria #
all - tutte 82.878
article - articoli 68.017
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.362 0 0 78 276 396 319 374 456 422 506 293 242
2020/20213.636 187 382 142 295 119 331 150 310 446 325 376 573
2021/20224.569 169 500 508 249 184 299 739 377 265 73 488 718
2022/20233.556 630 348 130 374 595 565 59 224 383 36 155 57
2023/20242.049 125 274 166 170 122 159 155 156 96 141 237 248
2024/2025976 81 545 350 0 0 0 0 0 0 0 0 0
Totale 23.185